Swasakudori maathirai for Childhood Asthma

Clinical Evaluation of Swasakudori Maathirai for the management of Soolikanam (Childhood Asthma) in Children

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2019/12/022527

Enrollment

Registered

2019-12-27

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J452- Mild intermittent asthma

Interventions

Intervention1: Swasakudori Maathirai for the management of Soolikanam(Childhood Asthma): Swasakudori Maathirai for the management of Soolikanam(Childhood Asthma)Dosage:5-7 years:45 mg(bds) 8-12 yeras:

Eligibility

Inclusion criteria

Inclusion criteria: Cough,Wheezing,Tightness of chest,Shortness of breath,Abdominal bloating,Loss of appetite

Exclusion criteria

Exclusion criteria: Haemoptysis,Active Primary complex,Congenital Heart diseases,Pneumonia, Any other serious illness

Design outcomes

Primary

Measure	Time frame
Efficacy of the trial drug is measured by peak expiratory flow meterTimepoint: Fourty Sixth day	—

Secondary

Measure	Time frame
Reduction in the recurrence of the disease and improvement in the quality of life of children Improvement in clinical symptomsTimepoint: Fourty sixth day	—

Countries

India

Contacts

Public ContactDr Srinivasan C

National Institute of Siddha

Gvennils@gmail.com9789093986

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026